NCT01541358

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Detailed description

The objective of the study is to use 18F sodium fluoride (fluorine F-18 sodium fluoride) PET/CT scanning to detect and characterize lesions in patients who have suspected skeletal malignancy. We hypothesize that scanning with 18F-NaF (fluorine F-18 sodium fluoride) is more sensitive for skeletal abnormalities and may better characterize lesions than conventional imaging.

Conditions

• Bone Cancer

Interventions

Type	Name	Description
RADIATION	fluorine F 18 sodium fluoride	Undergo fluorine F 18 sodium fluoride PET/CT scan
PROCEDURE	positron emission tomography/computed tomography	Undergo fluorine F 18 sodium fluoride PET/CT scan

Timeline

• Start date: 2012-05-01
• Primary completion: 2012-09-01
• Completion: 2012-09-01
• First posted: 2012-02-29
• Last updated: 2017-06-14
• Results posted: 2017-06-14

Locations

1 site across 1 country: United States